GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Ending Cash Position

Aptahem AB (XSAT:APTA) Ending Cash Position : kr3.60 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Ending Cash Position?

Aptahem AB's Ending Cash Position for the quarter that ended in Jun. 2024 was kr3.60 Mil.

Aptahem AB's quarterly Ending Cash Position increased from Dec. 2023 (kr2.09 Mil) to Mar. 2024 (kr3.50 Mil) and increased from Mar. 2024 (kr3.50 Mil) to Jun. 2024 (kr3.60 Mil).

Aptahem AB's annual Ending Cash Position declined from Dec. 2021 (kr46.24 Mil) to Dec. 2022 (kr20.23 Mil) and declined from Dec. 2022 (kr20.23 Mil) to Dec. 2023 (kr2.09 Mil).

Aptahem AB Ending Cash Position Historical Data

The historical data trend for Aptahem AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Ending Cash Position Chart

Aptahem AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.88 28.56 46.24 20.23 2.09

Aptahem AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.78 2.91 2.09 3.50 3.60

Aptahem AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aptahem AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=20.23+-18.139
=2.09

Aptahem AB's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3.499+0.098
=3.60

Aptahem AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Ending Cash Position
Comparable Companies
XSAT:DBP B OSTO:ONCOZ OSTO:2CUREX OSTO:CMOTEC B XSAT:CHOSA OSTO:MODTX OSTO:FLUI OSTO:LPGO OSTO:SCOL OSTO:EXPRS2 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
94V:Germany
Address
Norra Vallgatan 58, Malmo, SWE, 211 22
Website
http://www.aptahem.com
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB Headlines

No Headlines